CRISPR links to long noncoding RNA function in mice: A practical approach.

Abstract:

:Next generation sequencing has uncovered a trove of short noncoding RNAs (e.g., microRNAs) and long noncoding RNAs (lncRNAs) that act as molecular rheostats in the control of diverse homeostatic processes. Meanwhile, the tsunamic emergence of clustered regularly interspaced short palindromic repeats (CRISPR) editing has transformed our influence over all DNA-carrying entities, heralding global CRISPRization. This is evident in biomedical research where the ease and low-cost of CRISPR editing has made it the preferred method of manipulating the mouse genome, facilitating rapid discovery of genome function in an in vivo context. Here, CRISPR genome editing components are updated for elucidating lncRNA function in mice. Various strategies are highlighted for understanding the function of lncRNAs residing in intergenic sequence space, as host genes that harbor microRNAs or other genes, and as natural antisense, overlapping or intronic genes. Also discussed is CRISPR editing of mice carrying human lncRNAs as well as the editing of competing endogenous RNAs. The information described herein should assist labs in the rigorous design of experiments that interrogate lncRNA function in mice where complex disease processes can be modeled thus accelerating translational discovery.

journal_name

Vascul Pharmacol

journal_title

Vascular pharmacology

authors

Miano JM,Long X,Lyu Q

doi

10.1016/j.vph.2019.02.004

subject

Has Abstract

pub_date

2019-03-01 00:00:00

pages

1-12

eissn

1537-1891

issn

1879-3649

pii

S1537-1891(19)30041-2

journal_volume

114

pub_type

杂志文章,评审
  • Regional differences in the vasorelaxing effects of testosterone and its 5-reduced metabolites in the canine vasculature.

    abstract::Although the vasorelaxing effects of testosterone (T) and various androgen metabolites have been observed in a variety of blood vessels and species, previous studies have not systematically compared the vasorelaxing effects of androgen metabolites in different vascular beds within the same species. Therefore, we studi...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.vph.2012.01.008

    authors: Perusquía M,Espinoza J,Montaño LM,Stallone JN

    更新日期:2012-03-01 00:00:00

  • Endothelial microparticles: Pathogenic or passive players in endothelial dysfunction in autoimmune rheumatic diseases?

    abstract::Autoimmune rheumatic diseases are characterised by systemic inflammation and complex immunopathology, with an increased risk of cardiovascular disease, initiated by endothelial dysfunction in a chronic inflammatory environment. Endothelial microparticles (EMPs) are released into the circulation from activated endothel...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.vph.2016.05.016

    authors: McCarthy EM,Wilkinson FL,Parker B,Alexander MY

    更新日期:2016-11-01 00:00:00

  • Paclitaxel chemotherapy and vascular toxicity as assessed by flow-mediated and nitrate-mediated vasodilatation.

    abstract:BACKGROUND:Antitumor activity of paclitaxel is based on promotion of abnormal microtubule (MT) assembly but it is also considered to have significant pro-inflammatory and anti-angiogenic effects in vivo and thus may cause vascular dysfunction. METHODS:We studied 27 women treated with paclitaxel-containing combinations...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.vph.2010.05.002

    authors: Vassilakopoulou M,Mountzios G,Papamechael C,Protogerou AD,Aznaouridis K,Katsichti P,Venetsanou K,Dimopoulos MA,Ikonomidis I,Papadimitriou CA

    更新日期:2010-09-01 00:00:00

  • Contractile effect of ghrelin on isolated guinea-pig renal arteries.

    abstract::Ghrelin, a 28-amino acid peptide, known to exist in both acylated and des-acylated varieties, was identified as the first endogenous ligand of growth hormone secretagogue receptor in 1999. Various arteries are known to express ghrelin receptors, but the direct action of ghrelin on blood vessels has been unclear. In th...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.vph.2007.03.004

    authors: Dimitrova DZ,Mihov DN,Wang R,Hristov KL,Rizov LI,Bolton TB,Duridanova DB

    更新日期:2007-07-01 00:00:00

  • Vasodilatation produced by fasudil mesylate in vivo and in vitro.

    abstract::To investigate the vasorelaxant effect of fasudil mesylate (FM) in vivo and in vitro. The relaxation effect of FM was studied using cerebral vasospasm (CVS) model in vivo and isolated aortic rings in vitro. FM (0.35, 1.2, 3.5 mg·kg⁻¹) increased cerebrovascular flow (CVF) and femoral blood flow (FBF) dose-dependently i...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.vph.2011.06.005

    authors: Li Q,Chen Y,Sun L,Fu G,Guo L

    更新日期:2011-11-01 00:00:00

  • Propionyl-L-carnitine induces eNOS activation and nitric oxide synthesis in endothelial cells via PI3 and Akt kinases.

    abstract::Propionyl-l-carnitine (PLC) is a natural short-chain derivative of l-carnitine (LC), a natural amino acid that plays an important role in fatty acid metabolism. Recent studies suggest that PLC has vascular protective effects. Because of the importance of endothelial nitric oxide synthase (eNOS) and its product, antiat...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.vph.2013.07.001

    authors: Ning WH,Zhao K

    更新日期:2013-09-01 00:00:00

  • Recent developments in the effects of nitric oxide-donating statins on cardiovascular disease through regulation of tetrahydrobiopterin and nitric oxide.

    abstract::Since the discovery of the importance of nitric oxide (NO) to the human body three decades ago, numerous laboratory and clinical studies have been done to explore its potential therapeutic actions on many organs. In the cardiovascular system, NO works as a volatile signaling molecule regulating the vascular permeabili...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.vph.2014.08.001

    authors: Ma S,Ma CC

    更新日期:2014-11-01 00:00:00

  • Hydrogen sulfide: regulatory role on blood pressure in hyperhomocysteinemia.

    abstract::Hyperhomocysteinemia (HHcy) is a metabolic disorder marked by an excess amount of the amino acid homocysteine (Hcy) in the blood stream. Hcy is a H(2)S precursor-formed from the metabolism of methionine. Elevated Hcy levels have been associated with higher blood pressure. However, the precise contribution of H(2)S to ...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.vph.2010.05.004

    authors: Sowmya S,Swathi Y,Yeo AL,Shoon ML,Moore PK,Bhatia M

    更新日期:2010-09-01 00:00:00

  • Cyclic AMP relaxation of rat aortic smooth muscle is mediated in part by decrease of depletion of intracellular Ca(2+) stores and inhibition of capacitative calcium entry.

    abstract::Despite a large number of studies, the mechanism by which 3',5'-cyclic monophosphate (cAMP) induces vasorelaxation is not fully understood. The comparison between results obtained in different vessels or species has often been the source of conflicting reports. In order to shed more light onto this mechanism, we studi...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.vph.2012.08.007

    authors: Cuíñas A,Elíes J,Orallo F,Campos-Toimil M

    更新日期:2013-01-01 00:00:00

  • Chemerin-induced arterial contraction is Gi- and calcium-dependent.

    abstract::Chemerin is an adipokine associated with increased blood pressure, and may link obesity with hypertension. We tested the hypothesis that chemerin-induced contraction of the vasculature occurs via calcium flux in smooth muscle cells. Isometric contraction of rat aortic rings was performed in parallel with calcium kinet...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.vph.2016.11.009

    authors: Ferland DJ,Darios ES,Neubig RR,Sjögren B,Truong N,Torres R,Dexheimer TS,Thompson JM,Watts SW

    更新日期:2017-01-01 00:00:00

  • Cyclopiazonic acid alters serotonin-induced responses in rat thoracic aorta.

    abstract::We previously showed that endothelin A (ETA) receptor antagonist BQ-123 partially inhibited cyclopiazonic acid (CPA)-enhanced endothelin-1 (ET-1)-induced contractions suggesting enhancement of ETA receptor internalization in caveolar structures by sarco/endoplasmic reticulum Ca+2 ATPase (SERCA) blockade. Since seroton...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.vph.2014.03.008

    authors: Selli C,Erac Y,Tosun M

    更新日期:2014-05-01 00:00:00

  • PCSK9 inhibition for the treatment of hypercholesterolemia: promises and emerging challenges.

    abstract::Hypercholesterolemia, is a prominent risk factor for cardiovascular disease (CVD). Undestanding of the biochemical mechanisms that regulate the expression of the low density lipoproteins receptor (LDLR) and the hepatic clearance of LDL cholesterol (LDL-C) paved the way to the statin therapy as the gold standard for CV...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.vph.2014.05.011

    authors: Norata GD,Tibolla G,Catapano AL

    更新日期:2014-08-01 00:00:00

  • B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice.

    abstract:OBJECTIVE:Intranasal immunization with a fusion protein of the ApoB100-derived peptide p210 and the cholera toxin B subunit (CTB-p210) has previously been shown to induce mucosal tolerance and reduce atherosclerosis development, but the exact mode of action remains to be elucidated. Recent studies have indicated an imp...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.vph.2018.09.002

    authors: Rattik S,Mantani PT,Yao Mattisson I,Ljungcrantz I,Sundius L,Björkbacka H,Terrinoni M,Lebens M,Holmgren J,Nilsson J,Wigren M,Nordin Fredrikson G

    更新日期:2018-12-01 00:00:00

  • Mechanisms of endothelial cell protection by hydroxycinnamic acids.

    abstract::An endothelial dysfunction generates a proatherogenic environment characterized by stimulating thrombus formation. Epidemiological studies have provided evidence of a protective role of healthy diets in the prevention of cardiovascular diseases. Hydroxycinnamic acids constitute abundant polyphenols in our diets as the...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.vph.2014.10.006

    authors: Fuentes E,Palomo I

    更新日期:2014-12-01 00:00:00

  • Genetic polymorphisms modify the response of factor VII to oral contraceptive use: an example of gene-environment interaction.

    abstract::Elevated plasma levels of factor VII and fibrinogen are risk factors for cardiovascular disease, especially arterial thrombosis. Oral contraceptive use increases factor VII and fibrinogen plasma levels. It has been described that DNA polymorphisms are associated with the plasma levels of hemostatic variables and their...

    journal_title:Vascular pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s1537-1891(02)00300-2

    authors: Bloemenkamp KW,de Maat MP,Dersjant-Roorda MC,Helmerhorst FM,Kluft C

    更新日期:2002-08-01 00:00:00

  • Differential effects of ouabain on the vasodilator actions of nitric oxide and S-nitrosothiols in vivo: relevance to the identity of EDRF/EDHF.

    abstract:OBJECTIVES:This study examined the role of Na+/K+-ATPase in the vasodilator actions of nitric oxide (NO), S-nitrosothiols and the endothelium-dependent agonist, acetylcholine. METHODS:The vasodilator responses elicited by intravenous injections of (i) the NO-donors, sodium nitroprusside and MAHMA NONOate, (ii) the S-n...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.vph.2006.06.008

    authors: Lewis SJ,Travis MD,Hashmi-Hill MP,Sandock K,Robertson TP,Bates JN

    更新日期:2006-12-01 00:00:00

  • The Fra-2 transgenic mouse model of systemic sclerosis.

    abstract::In systemic sclerosis, microvascular injury often precedes the development of fibrosis. Whereas the development of digital ulcers and skin fibrosis causes high morbidity, the affection of internal organs, in particular complications such as interstitial lung disease and pulmonary (arterial) hypertension, account for t...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.vph.2012.12.001

    authors: Maurer B,Distler JH,Distler O

    更新日期:2013-03-01 00:00:00

  • Vascular AMPK as an attractive target in the treatment of vascular complications of obesity.

    abstract::The key for the survival of all organisms is the regulation and control of energy metabolism. Thus, several strategies have evolved in each tissue in order to balance nutrient supply with energy demand. Adenosine monophosphate-activated protein kinase (AMPK) is now recognized as a key participant in energy metabolism....

    journal_title:Vascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.vph.2015.02.017

    authors: García-Prieto CF,Gil-Ortega M,Aránguez I,Ortiz-Besoain M,Somoza B,Fernández-Alfonso MS

    更新日期:2015-04-01 00:00:00

  • Doxorubicin selectively suppresses mRNA expression and production of endothelin-1 in endothelial cells.

    abstract::Doxorubicin (DXR) is a widely used cytostatic agent, but its administration is limited by its cardiovascular side effects. The endothelium is one of the largest organs in the human body and due to its direct contact with blood; it is exposed to the toxic effects of DXR. The aim of this study was to investigate in endo...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.vph.2010.08.001

    authors: Keltai K,Cervenak L,Makó V,Doleschall Z,Zsáry A,Karádi I

    更新日期:2010-11-01 00:00:00

  • Aldosterone signaling modifies capillary formation by human bone marrow endothelial cells.

    abstract::We investigated the regulation of the epithelial sodium channel (ENaC) in human bone marrow endothelial cells (HBMEC) responding to mineralocorticoid hormones and other accessory effectors. The message for both the mineralocorticoid receptor (MCR) and the alpha subunit of ENaC was expressed in HBMEC as predicted bands...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.vph.2003.08.003

    authors: Chen W,Valamanesh F,Mirshahi T,Soria J,Tang R,Agarwal MK,Mirshahi M

    更新日期:2004-01-01 00:00:00

  • Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins.

    abstract::Impaired endothelial function is recognised as one of the earliest events of atherogenesis. Endothelium-dependent vasomotion has been the principal method to assess endothelial function. In this article, we will discuss the clinical value of the different techniques to evaluate endothelium-dependent vasomotion. To dat...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.vph.2005.01.009

    authors: Asselbergs FW,van der Harst P,Jessurun GA,Tio RA,van Gilst WH

    更新日期:2005-02-01 00:00:00

  • The influence of Sacoglottis gabonensis stem bark extract and its isolate bergenin, Nigerian alcoholic beverage additives, on the metabolic and haematological side effects of 2,4-dinitrophenyl hydrazine-induced tissue damage.

    abstract::This study was designed to study the influence of Sacoglottis gabonensis stem bark extract on the metabolic and cytotoxic side effects of 2,4-dinitrophenyl hydrazine (2,4-DNPH) on the brain and blood using male weaving rats as the experimental model. This was after the effect of the bark extract and bergenin, its isol...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/s1537-1891(03)00042-9

    authors: Maduka HC,Okoye ZS,Eje A

    更新日期:2002-12-01 00:00:00

  • PGC-1α ameliorates AngiotensinII-induced eNOS dysfunction in human aortic endothelial cells.

    abstract::Increasing evidences support that PGC-1α participates in regulating endothelial homeostasis, in part by mediating endothelial nitric oxide (NO) synthase (eNOS) activity and NO production. However, the molecular mechanisms by which PGC-1α regulates eNOS activity are not completely understood. In the present study, we i...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.vph.2016.05.005

    authors: Li J,Geng XY,Cong XL

    更新日期:2016-08-01 00:00:00

  • Effects of nitric oxide synthase inhibitors and melatonin on the hyperglycemic response to streptozotocin in rats.

    abstract::Recent studies evidence that peroxynitrite is spontaneously formed when nitric oxide (NO) and superoxide coexist and suggest that it is likely to be involved in the destruction of the pancreatic beta cells. We examined whether drugs that inhibit nitric oxide synthase (NOS) or scavenge peroxynitrite could abrogate STZ-...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/s1537-1891(02)00212-4

    authors: Rao VS,Santos FA,Silva RM,Teixiera MG

    更新日期:2002-03-01 00:00:00

  • Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats.

    abstract::Our previous studies in heterozygous Ren-2 transgenic rats (TGR) have shown that early treatment with selective endothelin (ET)(A) receptor blockade is superior to nonselective ET(A/B) receptor blockade. The aim of this study was to evaluate the role of the ET system in male heterozygous TGR with established hypertens...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.vph.2008.01.009

    authors: Vernerová Z,Kramer HJ,Bäcker A,Cervenka L,Opocenský M,Husková Z,Vanourková Z,Eis V,Chábová VC,Tesar V,Malý J,Vanecková I

    更新日期:2008-04-01 00:00:00

  • Epigenetic modulators mitigate angiogenesis through a complex transcriptomic network.

    abstract::In this review, we summarize the knowledge pertaining to the role of epigenetics in the regulation of angiogenesis. In particular, we show that lysine acetylation and cytosine methylation are important transcriptional regulators of angiogenic genes in endothelial cells. Lysine acetylation and cytosine methylation inhi...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.vph.2014.01.003

    authors: Shiva Shankar TV,Willems L

    更新日期:2014-02-01 00:00:00

  • An updated view on stem cell differentiation into smooth muscle cells.

    abstract::Stem cells possess the ability of self-renewal and give rise to specific cell types. The differentiation of stem cells involves environmental factors, transduction of extra and intra-cellular signals, regulation of gene expression by transcriptional factors, microRNAs and chromosome structural modifiers. Vascular SMCs...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.vph.2012.02.014

    authors: Zhang L,Zhou Y,Zhu J,Xu Q

    更新日期:2012-05-01 00:00:00

  • Intra-aortic balloon counterpulsation - basic principles and clinical evidence.

    abstract::Intra-aortic balloon pump (IABP) counterpulsation has been the most widely used left ventricular assist device for nearly five decades. Due to diastolic inflation and systolic deflation, coronary blood flow is increased and afterload decreased translating into augmentation of oxygen supply and lowering of oxygen deman...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.vph.2013.12.003

    authors: de Waha S,Desch S,Eitel I,Fuernau G,Lurz P,Sandri M,Schuler G,Thiele H

    更新日期:2014-02-01 00:00:00

  • Activation of endothelial TrkB receptors induces relaxation of resistance arteries.

    abstract::While brain-derived neurotrophic factor (BDNF) was previously reported to induce relaxation of conduit artery, whether the BDNF/TrkB (tropomyosin-related kinase) pathway is involved in the tone control of resistance arteries is not known. This study investigated TrkB receptors levels/localization and the vasomotor eff...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.vph.2018.02.005

    authors: Totoson P,Pedard M,Marie C,Demougeot C

    更新日期:2018-07-01 00:00:00

  • Role of altered coagulation-fibrinolytic system in the pathophysiology of diabetic retinopathy.

    abstract::The implications of altered coagulation-fibrinolytic system in the pathophysiology of several vascular disorders, such as stroke and myocardial infarction, have been well researched upon and established. However, its role in the progression of diabetic retinopathy has not been explored much. Since a decade, it is know...

    journal_title:Vascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.vph.2017.03.005

    authors: Behl T,Velpandian T,Kotwani A

    更新日期:2017-05-01 00:00:00